Haoxi Health Technology (NASDAQ:HAO) Upgraded by Wall Street Zen to Hold Rating

by · The Cerbat Gem

Wall Street Zen upgraded shares of Haoxi Health Technology (NASDAQ:HAO – Free Report) to a hold rating in a report released on Saturday morning.

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of Haoxi Health Technology in a research report on Friday, July 17th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, Haoxi Health Technology has a consensus rating of “Sell”.

View Our Latest Report on HAO

Haoxi Health Technology Trading Up 22.3%

Shares of NASDAQ:HAO opened at $3.98 on Friday. Haoxi Health Technology has a 12-month low of $2.70 and a 12-month high of $5,708.80. The business’s fifty day simple moving average is $12.22 and its 200-day simple moving average is $1,495.75.

About Haoxi Health Technology

(Get Free Report)

Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo.

Featured Articles